Efficacy and Safety of Intranasal Betahistine in the Treatment of Surgery-Induced Acute Vestibular Syndrome: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study

Overview of attention for article published in Otology & Neurotology, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 3,961)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 8,118 followers.

RT @OandNonline: Intranasal #betahistine may accelerate vestibular compensation in acute vestibular syndrome. #Dizziness https://t.co/DNHc…

RT @OandNonline: Intranasal #betahistine may accelerate vestibular compensation in acute vestibular syndrome. #Dizziness https://t.co/DNHc…

RT @OandNonline: Intranasal #betahistine may accelerate vestibular compensation in acute vestibular syndrome. #Dizziness https://t.co/DNHc…

RT @OandNonline: Intranasal #betahistine may accelerate vestibular compensation in acute vestibular syndrome. #Dizziness https://t.co/DNHc…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.